AKT1 and diabetes mellitus: Similarly, both empagliflozin-treated DM rats and liraglutide-treated DM rats had an increased the ratio of phosphorylated protein kinase B (pAkt) (Ser 473) to protein kinase B (Akt) compared with DM rats (Figure 3d).